439 related articles for article (PubMed ID: 31320448)
1. Diverse Mechanisms Lead to Common Dysfunction of Striatal Cholinergic Interneurons in Distinct Genetic Mouse Models of Dystonia.
Eskow Jaunarajs KL; Scarduzio M; Ehrlich ME; McMahon LL; Standaert DG
J Neurosci; 2019 Sep; 39(36):7195-7205. PubMed ID: 31320448
[TBL] [Abstract][Full Text] [Related]
2. Strength of cholinergic tone dictates the polarity of dopamine D2 receptor modulation of striatal cholinergic interneuron excitability in DYT1 dystonia.
Scarduzio M; Zimmerman CN; Jaunarajs KL; Wang Q; Standaert DG; McMahon LL
Exp Neurol; 2017 Sep; 295():162-175. PubMed ID: 28587876
[TBL] [Abstract][Full Text] [Related]
3. Investigating the role of striatal dopamine receptor 2 in motor coordination and balance: Insights into the pathogenesis of DYT1 dystonia.
Liu Y; Xing H; Yokoi F; Vaillancourt DE; Li Y
Behav Brain Res; 2021 Apr; 403():113137. PubMed ID: 33476687
[TBL] [Abstract][Full Text] [Related]
4. Decreased number of striatal cholinergic interneurons and motor deficits in dopamine receptor 2-expressing-cell-specific Dyt1 conditional knockout mice.
Yokoi F; Oleas J; Xing H; Liu Y; Dexter KM; Misztal C; Gerard M; Efimenko I; Lynch P; Villanueva M; Alsina R; Krishnaswamy S; Vaillancourt DE; Li Y
Neurobiol Dis; 2020 Feb; 134():104638. PubMed ID: 31618684
[TBL] [Abstract][Full Text] [Related]
5. Negative allosteric modulation of mGlu5 receptor rescues striatal D2 dopamine receptor dysfunction in rodent models of DYT1 dystonia.
Sciamanna G; Ponterio G; Tassone A; Maltese M; Madeo G; Martella G; Poli S; Schirinzi T; Bonsi P; Pisani A
Neuropharmacology; 2014 Oct; 85():440-50. PubMed ID: 24951854
[TBL] [Abstract][Full Text] [Related]
6. Regional specificity of synaptic plasticity deficits in a knock-in mouse model of DYT1 dystonia.
Martella G; Maltese M; Nisticò R; Schirinzi T; Madeo G; Sciamanna G; Ponterio G; Tassone A; Mandolesi G; Vanni V; Pignatelli M; Bonsi P; Pisani A
Neurobiol Dis; 2014 May; 65():124-32. PubMed ID: 24503369
[TBL] [Abstract][Full Text] [Related]
7. Enhanced mu opioid receptor-dependent opioidergic modulation of striatal cholinergic transmission in DYT1 dystonia.
Ponterio G; Tassone A; Sciamanna G; Vanni V; Meringolo M; Santoro M; Mercuri NB; Bonsi P; Pisani A
Mov Disord; 2018 Feb; 33(2):310-320. PubMed ID: 29150865
[TBL] [Abstract][Full Text] [Related]
8. Cholinergic dysregulation produced by selective inactivation of the dystonia-associated protein torsinA.
Sciamanna G; Hollis R; Ball C; Martella G; Tassone A; Marshall A; Parsons D; Li X; Yokoi F; Zhang L; Li Y; Pisani A; Standaert DG
Neurobiol Dis; 2012 Sep; 47(3):416-27. PubMed ID: 22579992
[TBL] [Abstract][Full Text] [Related]
9. Developmental profile of the aberrant dopamine D2 receptor response in striatal cholinergic interneurons in DYT1 dystonia.
Sciamanna G; Tassone A; Martella G; Mandolesi G; Puglisi F; Cuomo D; Madeo G; Ponterio G; Standaert DG; Bonsi P; Pisani A
PLoS One; 2011; 6(9):e24261. PubMed ID: 21912682
[TBL] [Abstract][Full Text] [Related]
10. Dopamine D2 receptor dysfunction is rescued by adenosine A2A receptor antagonism in a model of DYT1 dystonia.
Napolitano F; Pasqualetti M; Usiello A; Santini E; Pacini G; Sciamanna G; Errico F; Tassone A; Di Dato V; Martella G; Cuomo D; Fisone G; Bernardi G; Mandolesi G; Mercuri NB; Standaert DG; Pisani A
Neurobiol Dis; 2010 Jun; 38(3):434-45. PubMed ID: 20227500
[TBL] [Abstract][Full Text] [Related]
11. Altered responses to dopaminergic D2 receptor activation and N-type calcium currents in striatal cholinergic interneurons in a mouse model of DYT1 dystonia.
Pisani A; Martella G; Tscherter A; Bonsi P; Sharma N; Bernardi G; Standaert DG
Neurobiol Dis; 2006 Nov; 24(2):318-25. PubMed ID: 16934985
[TBL] [Abstract][Full Text] [Related]
12. Striatal cholinergic dysfunction as a unifying theme in the pathophysiology of dystonia.
Eskow Jaunarajs KL; Bonsi P; Chesselet MF; Standaert DG; Pisani A
Prog Neurobiol; 2015 Apr; 127-128():91-107. PubMed ID: 25697043
[TBL] [Abstract][Full Text] [Related]
13. Blockade of M4 muscarinic receptors on striatal cholinergic interneurons normalizes striatal dopamine release in a mouse model of TOR1A dystonia.
Downs AM; Donsante Y; Jinnah HA; Hess EJ
Neurobiol Dis; 2022 Jun; 168():105699. PubMed ID: 35314320
[TBL] [Abstract][Full Text] [Related]
14. Rhes regulates dopamine D2 receptor transmission in striatal cholinergic interneurons.
Sciamanna G; Napolitano F; Pelosi B; Bonsi P; Vitucci D; Nuzzo T; Punzo D; Ghiglieri V; Ponterio G; Pasqualetti M; Pisani A; Usiello A
Neurobiol Dis; 2015 Jun; 78():146-61. PubMed ID: 25818655
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the direct pathway in Dyt1 ΔGAG heterozygous knock-in mice and dopamine receptor 1-expressing-cell-specific Dyt1 conditional knockout mice.
Yokoi F; Chen HX; Oleas J; Dang MT; Xing H; Dexter KM; Li Y
Behav Brain Res; 2021 Aug; 411():113381. PubMed ID: 34038798
[TBL] [Abstract][Full Text] [Related]
16. Decreased dopamine receptor 1 activity and impaired motor-skill transfer in Dyt1 ΔGAG heterozygous knock-in mice.
Yokoi F; Dang MT; Liu J; Gandre JR; Kwon K; Yuen R; Li Y
Behav Brain Res; 2015 Feb; 279():202-10. PubMed ID: 25451552
[TBL] [Abstract][Full Text] [Related]
17. Cell-intrinsic effects of TorsinA(ΔE) disrupt dopamine release in a mouse model of TOR1A dystonia.
Downs AM; Fan X; Kadakia RF; Donsante Y; Jinnah HA; Hess EJ
Neurobiol Dis; 2021 Jul; 155():105369. PubMed ID: 33894367
[TBL] [Abstract][Full Text] [Related]
18. A cell autonomous torsinA requirement for cholinergic neuron survival and motor control.
Pappas SS; Li J; LeWitt TM; Kim JK; Monani UR; Dauer WT
Elife; 2018 Aug; 7():. PubMed ID: 30117805
[TBL] [Abstract][Full Text] [Related]
19. Electrophysiological characterization of the striatal cholinergic interneurons in
Xing H; Yokoi F; Walker AL; Torres-Medina R; Liu Y; Li Y
Dystonia; 2022 Jul; 1():. PubMed ID: 36329866
[TBL] [Abstract][Full Text] [Related]
20. Optogenetic augmentation of the hypercholinergic endophenotype in DYT1 knock-in mice induced erratic hyperactive movements but not dystonia.
Richter F; Bauer A; Perl S; Schulz A; Richter A
EBioMedicine; 2019 Mar; 41():649-658. PubMed ID: 30819512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]